WireIsrael.com

Samsung Bioepis

Found 1 recent publications

Today, Nov 3
14:25
Teva Reports Q3 Revenue of $4.4 Billion, Raises Full-Year Outlook
Business

Teva Reports Q3 Revenue of $4.4 Billion, Raises Full-Year Outlook

Teva Pharmaceutical reported Q3 revenue of $4.4 billion and non-GAAP EPS of 86 cents, beating Wall Street forecasts. The company raised its full-year revenue outlook to $16.7-17 billion.

Showing latest 50 articles for this tag